Back to Journals » International Journal of Nanomedicine » Volume 8 » Issue 1
Nano-BaSO4: a novel antimicrobial additive to pellethane
Authors Aninwene II G, Stout D, Yang Z, Webster TJ
Received 14 November 2012
Accepted for publication 21 December 2012
Published 22 March 2013 Volume 2013:8(1) Pages 1197—1205
DOI https://doi.org/10.2147/IJN.S40300
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
George E Aninwene II,1 David Stout,2 Zifan Yang,2 Thomas J Webster1
1Program in Bioengineering and Department of Chemical Engineering, Northeastern University, Boston, MA, USA; 2School of Engineering, Brown University, Providence, RI, USA
Abstract: Hospital-acquired infections remain a costly clinical problem. Barium sulfate (BaSO4, in micron particulate form) is a common radiopacifying agent that is added to catheters and endotracheal tubes. Due to the recently observed ability of nanostructured surface features to decrease functions of bacteria without the aid of antibiotics, the objective of this in vitro study was to incorporate nano-barium sulfate into pellethane and determine the antimicrobial properties of the resulting composites. The results demonstrated for the first time that the incorporation of nano-barium sulfate into pellethane enhanced antimicrobial properties (using Staphylococcus aureus and Pseudomonas aeruginosa) compared to currently used pellethane; properties that warrant further investigation for a wide range of clinical applications.
Keywords: antimicrobial polymer, hospital-acquired infections, surface roughness, radiopaque agent, dynamic contact microbial testing
© 2013 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.